Drug Type Recombinant protein, Diagnostic radiopharmaceuticals |
Synonyms 99mTc-rhAnnexin V-128, 99mTechnetium-labelled rhAnnexin V-128, Tc-99m-recombinant human annexin V-128 + [2] |
Target |
Mechanism Phosphatidylserine inhibitors(Phosphatidylserine inhibitors), SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ankylosing Spondylitis | Phase 2 | - | - | |
Ankylosing Spondylitis | Phase 2 | - | - | |
Cardiomyopathy, Hypertrophic | Phase 2 | - | - | |
Cardiomyopathy, Hypertrophic | Phase 2 | - | - | |
Cardiomyopathy, Hypertrophic | Phase 2 | - | - | |
Cardiomyopathy, Hypertrophic | Phase 2 | - | - | |
Rheumatoid Arthritis | Phase 2 | - | - | |
Rheumatoid Arthritis | Phase 2 | - | - | |
Rheumatoid Arthritis | Phase 2 | - | - | |
Cardiomyopathies | Phase 1 | CA | - |
Phase 1/2 | 16 | (99mTc-rhAnnexin V-128: Ankylosing Spondylitis) | (elxhukpqdh) = wvwwzqyrqc jssvlxjyvg (hlfyhyanlv, ikagujftgz - ibfnbvesem) View more | - | 09 Jun 2020 | ||
(99mTc-rhAnnexin V-128: Rheumatoid Arthritis) | (elxhukpqdh) = uormdxispq jssvlxjyvg (hlfyhyanlv, sispoqyhmh - eauyigrcmi) View more | ||||||
Phase 2 | 5 | dhquhwcvws(lmrkxkwfqu) = ribtnuromh okkfnlduom (mtyncqatbx, lmedeutxrc - veltndcrfv) View more | - | 13 Dec 2019 |